Literature DB >> 22797528

Does 'altitude training' increase exercise performance in elite athletes?

Carsten Lundby1, Gregoire P Millet, Jose A Calbet, Peter Bärtsch, Andrew W Subudhi.   

Abstract

The general practice of altitude training is widely accepted as a means to enhance sport performance despite a lack of rigorous scientific studies. For example, the scientific gold-standard design of a double-blind, placebo-controlled, cross-over trial has never been conducted on altitude training. Given that few studies have utilised appropriate controls, there should be more scepticism concerning the effects of altitude training methodologies. In this brief review we aim to point out weaknesses in theories and methodologies of the various altitude training paradigms and to highlight the few well-designed studies to give athletes, coaches and sports medicine professionals the current scientific state of knowledge on common forms of altitude training. Another aim is to encourage investigators to design well-controlled studies that will enhance our understanding of the mechanisms and potential benefits of altitude training.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22797528     DOI: 10.1136/bjsports-2012-091231

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  38 in total

Review 1.  Exercise, immune function and respiratory infection: An update on the influence of training and environmental stress.

Authors:  Neil P Walsh; Samuel J Oliver
Journal:  Immunol Cell Biol       Date:  2015-11-13       Impact factor: 5.126

2.  CrossTalk opposing view: Heat acclimatization does not improve exercise performance in a cool condition.

Authors:  Lars Nybo; Carsten Lundby
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

3.  Rebuttal by Lars Nybo and Carsten Lundby.

Authors:  Lars Nybo; Carsten Lundby
Journal:  J Physiol       Date:  2015-12-14       Impact factor: 5.182

4.  Endurance, aerobic high-intensity, and repeated sprint cycling performance is unaffected by normobaric "Live High-Train Low": a double-blind placebo-controlled cross-over study.

Authors:  Jacob Bejder; Andreas Breenfeldt Andersen; Rie Buchardt; Tanja Hultengren Larsson; Niels Vidiendal Olsen; Nikolai Baastrup Nordsborg
Journal:  Eur J Appl Physiol       Date:  2017-03-22       Impact factor: 3.078

5.  Hypoxic conditions and exercise-to-rest ratio are likely paramount.

Authors:  Grégoire P Millet; Raphael Faiss
Journal:  Sports Med       Date:  2012-12-01       Impact factor: 11.136

6.  Rhodiola crenulata- and Cordyceps sinensis-based supplement boosts aerobic exercise performance after short-term high altitude training.

Authors:  Chung-Yu Chen; Chien-Wen Hou; Jeffrey R Bernard; Chiu-Chou Chen; Ta-Cheng Hung; Lu-Ling Cheng; Yi-Hung Liao; Chia-Hua Kuo
Journal:  High Alt Med Biol       Date:  2014-09       Impact factor: 1.981

7.  Alterations in redox homeostasis in the elite endurance athlete.

Authors:  Nathan A Lewis; Glyn Howatson; Katie Morton; Jessica Hill; Charles R Pedlar
Journal:  Sports Med       Date:  2015-03       Impact factor: 11.136

8.  Training Quantification and Periodization during Live High Train High at 2100 M in Elite Runners: An Observational Cohort Case Study.

Authors:  Avish P Sharma; Philo U Saunders; Laura A Garvican-Lewis; Julien D Périard; Brad Clark; Christopher J Gore; Benjamin P Raysmith; Jamie Stanley; Eileen Y Robertson; Kevin G Thompson
Journal:  J Sports Sci Med       Date:  2018-11-20       Impact factor: 2.988

9.  Intermittent not continuous hypoxia provoked haematological adaptations in healthy seniors: hypoxic pattern may hold the key.

Authors:  Barbara Tobin; Guillaume Costalat; Gillian M C Renshaw
Journal:  Eur J Appl Physiol       Date:  2020-02-14       Impact factor: 3.078

10.  Training Diaries during Altitude Training Camp in Two Olympic Champions: An Observational Case Study.

Authors:  Lorenzo Pugliese; Fabio R Serpiello; Grégoire P Millet; Antonio La Torre
Journal:  J Sports Sci Med       Date:  2014-09-01       Impact factor: 2.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.